Nephrology · Montebello, CA
NPI
1114910908
Since 2005
Specialty
Nephrology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3114 W Beverly Blvd
Montebello, CA, 90640
Phone (323) 726-3868
Groups this clinician bills Medicare through
Medicare paid, 2024
$229K
1,857 services
Medicare patients, 2024
513
Average age 71
Drug cost, 2024
$617K
2,955 prescriptions
Company payments, 2025
$1,661
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shamik Bhadra was code 99233 (hospital e&m - subsequent), 899 times for 284 patients. In total Shamik Bhadra billed 1,857 services in 20 codes, and Medicare paid $229K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-08-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 899 | 284 | $97.46 | $88K |
| 99223 Hospital E&M - Initial | Facility | 185 | 168 | $141.57 | $26K |
| 90960 ESRD Related Services (not dialysis) | Office | 179 | 99 | $290.47 | $52K |
| 99232 Hospital E&M - Subsequent | Facility | 91 | 41 | $63.30 | $5,760 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 83 | 44 | $13.09 | $1,087 |
| 99214 Office E&M - Established | Office | 81 | 43 | $82.60 | $6,690 |
| 90961 ESRD Related Services (not dialysis) | Office | 66 | 49 | $246.86 | $16K |
| 99291 Critical Care E&M | Facility | 53 | 30 | $167.90 | $8,899 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 50 | 13 | $53.02 | $2,651 |
| 99215 Office E&M - Established | Office | 35 | 18 | $140.20 | $4,907 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 25 | 12 | $41.74 | $1,044 |
By year: 2022 $175K for 1,305 services; 2023 $223K for 1,604 services; 2024 $229K for 1,857 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shamik Bhadra prescribed most often to Medicare patients was Losartan Potassium, with 330 prescriptions and refills. In total Shamik Bhadra wrote 2,955 Medicare prescriptions that cost $617K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Losartan Potassium Generic | 330 | 527 | 83 | $1,601 |
| Furosemide Generic | 243 | 402 | 61 | $793 |
| Lisinopril Generic | 188 | 302 | 52 | $588 |
| Lokelma Sodium Zirconium Cyclosilicate | 155 | 165 | 29 | $125K |
| Nifedipine Er Nifedipine | 95 | 130 | 20 | $1,605 |
| Calcitriol Generic | 95 | 135 | 19 | $1,074 |
| Chlorthalidone Generic | 90 | 137 | 21 | $870 |
| Metoprolol Succinate Generic | 90 | 127 | 22 | $654 |
| Kerendia Finerenone | 89 | 95 | 15 | $58K |
| Carvedilol Generic | 88 | 144 | 20 | $387 |
| Benazepril Hcl Generic | 79 | 145 | 22 | $713 |
| Amlodipine Besylate Generic | 76 | 118 | 18 | $213 |
| Veltassa Patiromer Calcium Sorbitex | 67 | 70 | 14 | $70K |
| Sevelamer Carbonate Generic | 67 | 105 | 19 | $12K |
| Velphoro Sucroferric Oxyhydroxide | 67 | 93 | 16 | $192K |
Brand drugs: 649 claims; generic drugs: 2,281 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shamik Bhadra $1,661 ($1,661 in general payments such as food, travel and fees) from 18 companies. The largest payer was Akebia Therapeutics Inc with $242.
| Company | Payments | Amount |
|---|---|---|
| Akebia Therapeutics Inc AKBA | 9 | $242 |
| Calliditas Therapeutics US Inc. | 7 | $191 |
| ANI Pharmaceuticals, Inc. ANIP | 6 | $172 |
| GlaxoSmithKline, LLC. GSK | 7 | $168 |
| Amgen Inc. AMGN | 10 | $138 |
| Ardelyx, Inc. ARDX | 4 | $114 |
| Travere Therapeutics, Inc. TVTX | 9 | $106 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $101 |
| Fresenius USA Marketing, Inc. | 4 | $96.87 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $80.53 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.